Pharming Group NV (PHARM) — Strategic Asset Allocation Index
Pharming Group NV (PHARM) has a Strategic Asset Allocation Index of 2.5% as of September 2025. Strategic assets (PP&E of €- plus long-term investments of €6.67 Million) total €6.67 Million, measured against net assets of €264.64 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Pharming Group NV (PHARM) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Pharming Group NV Strategic Asset Allocation Index (2013–2024)
This chart shows how Pharming Group NV's Strategic Asset Allocation Index has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the index stands at 2.5%, representing strategic assets of €6.67 Million against net assets of €264.64 Million EUR. For live market cap and overall valuation, see Pharming Group NV (PHARM) total market value.
Annual Strategic Asset Allocation Index for Pharming Group NV (2013–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Pharming Group NV from 2013 to 2024, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Pharming Group NV for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 2.0% | €4.23 Million | €- | €4.23 Million | €214.16 Million | ▼ -3.3 pp |
| 2023 | 5.3% | €10.40 Million | €- | €10.40 Million | €198.05 Million | ▼ -18.6 pp |
| 2022 | 23.9% | €48.88 Million | €39.15 Million | €9.73 Million | €204.64 Million | ▲ +2.1 pp |
| 2021 | 21.8% | €41.95 Million | €33.16 Million | €8.79 Million | €192.72 Million | ▲ +6.8 pp |
| 2020 | 14.9% | €27.45 Million | €21.65 Million | €5.80 Million | €183.73 Million | ▼ -3.5 pp |
| 2019 | 18.4% | €21.60 Million | €16.30 Million | €5.31 Million | €117.26 Million | ▲ +6.5 pp |
| 2018 | 11.9% | €8.40 Million | €8.40 Million | €- | €70.64 Million | ▼ -24.6 pp |
| 2017 | 36.5% | €8.23 Million | €8.23 Million | €- | €22.56 Million | ▲ +15.6 pp |
| 2016 | 20.9% | €6.04 Million | €6.04 Million | €- | €28.89 Million | ▼ -0.8 pp |
| 2015 | 21.7% | €5.66 Million | €5.66 Million | €- | €26.06 Million | ▲ +6.3 pp |
| 2014 | 15.4% | €5.60 Million | €5.60 Million | €- | €36.29 Million | ▼ -74.6 pp |
| 2013 | 90.0% | €6.23 Million | €6.23 Million | €- | €6.92 Million | — |